
Hikma Ventures
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Investor Profile
Hikma Ventures has made 25 investments, with 0 in the past 12 months and 28% as lead.
Stage Focus
- Series A (40%)
- Series B (28%)
- Seed (12%)
- Series C (8%)
- Series Unknown (4%)
- Series D (4%)
- Convertible Note (4%)
Country Focus
- United States (84%)
- Canada (8%)
- United Arab Emirates (4%)
- Egypt (4%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Mhealth
- Machine Learning
- Wearables
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.